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ABSTRACT: Sequence specific molecules with high folding ability (i.e. foldamers) can be used to precisely control the distribu-
tion and projection of side chains in space and have recently been introduced as tailored systems for delivering nucleic acids into 
cells. Designed oligourea sequences with an amphipathic distribution of Arg- and His-type residues were shown to form tight com-
plexes with plasmid DNA, and to effectively promote the release of DNA from the endosomes. Herein, we report the synthesis of 
new cell-penetrating foldamer sequences in which the foldamer segment is conjugated via a reducible disulfide bond to a ligand that 
binds cell-surface expressed nucleoproteins with the idea that this system could facilitate both assemblies with nucleic acids and 
cell entry. This new system was evaluated for delivery of DNA in several cell lines and was found to compare favorably with all 
comparators tested (DOTAP and b-PEI as well as a number of known cell penetrating peptides) in various cell lines and particularly 
in culture medium containing up to 50% of serum. These results suggest that this dual molecular platform which is long lasting and 
non-cytotoxic could be of practical use for in vivo applications.  
INTRODUCTION 
In recent years, in a context of research seeking for modern 
pharmaceutical strategies, there has been a strong interest 
in the development of new and safe transport systems for 
the intracellular delivery of drugs and biomolecules such as 
nucleic acids (NA). A large fraction of engineered molecu-
lar transporters are inspired by cell-penetrating peptides 
(CPPs)
1,2,3
 and share a common chemical feature i.e. the 
presence of multiple guanidinium units in their structure 
(either part of the main chain or as side chain appendages).
4
 
Guanidinium moieties facilitate cell intake by providing 
key interactions with anionic phosphate head groups of 
membrane lipids
5,6,7
 and also mediate NA condensation and 
transfection.
8,9
 Seminal works by Wender et al. have shown 
the possibility to efficiently mimic arginine-rich CPP with 
guanidinium-containing oligocarbamates,
10
 a class of back-
bone that has been reinvestigated recently by Kumar et al. 
for NA delivery.
11
 Meanwhile, with the advent of foldam-
ers,
12,13
 various folded molecular architectures have been 
investigated for their capacity to spontaneously cross cell-
membranes. Peptoids,
14,15,16 - and γ-peptides17,18,19,20,21,22 
and aromatic oligoamides
23,24 
have shown promising results 
in term of cellular uptake. It has been postulated that the 
folded topology of these synthetic oligomers could play a 
key role in cell-membrane crossing. In most cases the de-
fined helical geometry segregates the guanidinium moieties 
on one face of the structure thus conferring a facial amphi-
philicity to these folded systems.
25
 This concept was also 
applied successfully to α-peptides, recent examples includ-
ing the development of rigidified cationic polyproline II 
helix architectures,
26,27
 and stabilized α-helices containing 
either aliphatic or cationic α,α-disubstituted amino ac-
ids
28,29,30 
or hydrocarbon crosslinks between side chains.
31
 
Despite these significant advances, the interplay between 
folding, guanidinium distribution and cell penetration is 
often investigated in the absence of cargo and only few 
studies have reported cellular delivery of active molecules 
such as NAs.
25
  
In this context, we have recently designed a first generation 
of cationic urea-based cell-penetrating foldamers (CPFs) as 
gene delivery system and we have shown that by introduc-
ing thiol moieties for effective foldamer dimerization (e.g. 
1), we could 1) amplify the coating of 2.5-helical 
oligoureas on plasmid DNA (pDNA) and 2) facilitate the 
effective vector unpacking within the cell by a redox 
mechanism.
32
 The resulting foldamer/pDNA assemblies, 
referred to as foldaplexes, exhibited high transfection effi-
ciency with gene expression levels comparable to those 
obtained with branched polyethylenimine (b-PEI), N-[1-
(2,3-Dioleoyloxy)propyl]-N,N,N-trimethylammonium me-
thylsulfate (DOTAP) and LAH4 peptide, a potent 26-
residue long CPP developed for gene delivery.
33
 CPF 1 
which exhibits an amphipathic distribution of side chains 
along the 2.5-helix axis (Figure 1a), contains only one Arg- 
for two His-type residues per oligourea segment, the His-
type residues (His
U
) being introduced to promote en-
dosomal escape (i.e. so called proton sponge effect).
34,35
 
 In this work, we have considered the possibility to increase 
further the transfection efficacy by combining the CPF 
sequence used in 1 with a multimeric cationic (Arg-rich) 
pseudopeptide (N5L) reported to bind nucleoproteins in-
cluding cell-surface expressed nucleolin (NCL).
36,37
 
Figure 1. Helical wheel representation of oligourea and formulae 
of a) the 1st generation of homodimeric urea-based CPF (1) and b) 
2nd generation of urea-based foldamer-pseudopeptide hybrid (2).  
NCL is known to play a key role in a variety of cellular 
processes such as transcription, replication and recombina-
tion of DNA and its expression although primarily known 
to be nuclear and cytoplasmic is enhanced at the surface of 
activated endothelial cells and of various types of cancer 
cells.
38
 Several recent studies have highlighted the potential 
of using NCL ligands (e.g. aptamer AS1411,
39
 the homing 
tumor peptide F3,
40
 and multimeric pseudopeptides)
36,41
 as 
anticancer agents but also to mediate receptor endocytosis 
and deliver active molecules into cells. Herein, we report 
the synthesis of the urea-based foldamer-peptide hybrid 
dimer (2) in which the CPF sequence of 1 was conjugated 
to a NCL pseudopeptide ligand via a reducible disulfide 
bond. This new system was evaluated for delivery of 
pDNA in several cell lines and was directly compared to 
known CPPs, oligourea 1 as well as cognate homodimers 
(Dim8 and Dim9, vide infra). We found that heterodimer 2 
displays a remarkably high transfection efficacy, above that 
of the comparators in all cell lines tested and particularly in 
culture medium containing up to 50% of serum. These 
results suggest that this dual molecular platform could 
overcome some of the limitations of other NA delivery 
systems for in vivo applications.  
RESULTS AND DISCUSSION 
Hybrid Cell-Penetrating Foldamer Synthesis. The synthe-
sis of the cysteamine-functionalized CPF sequence 8 used 
for the preparation of heterodimer 2 is shown in Scheme 1. 
The sequence of 8 differs from that in 1 by the position of 
the ureido cysteamine moiety. This modification was intro-
duced to facilitate access of the corresponding oligourea 
using Boc chemistry by avoiding the need for the final HF 
cleavage of the resin. The solid-phase synthesis (SPS) 
using Boc chemistry is particularly robust, allowing the 
preparation of aliphatic oligoureas and related hybrids with 
good purities and yields.
42,43,44,45
 Here, the elongation of 
CPFs using Boc-protected activated monomers A was 
preferred over the use of azido building blocks
44 
and TFA-
labile resins, also because access to the activated His-type 
monomer required for such CPF sequences remains limited 
to its N-Boc protected version.
45
 Our new strategy relies on 
the use of a resin equipped with a cystamine linker that can 
be cleaved under reductive conditions to release the CPF 
with a terminal thiol-function. It is worth mentioning that 
compared to standard oligourea synthesis on MBHA resin, 
there is no more requirement to introduce a -amino acid at 
the first position (see 1),
32,46
 the cystamine-type linker and 
the first urea bond being stable to TFA treatment. Resins 
equipped with a cystamine linker have already been de-
scribed in literature
47
 and we hypothesized that besides its 
compatibility with the use of TFA needed for the succes-
sive, Boc deprotection steps, the disulfide bridge should 
also be resistant to microwave irradiation applied during 
the course of SPS. Resin 3 was prepared from MBHA resin 
as shown in scheme 1. To readily estimate the loading of 
resin 3 by colorimetric test (i.e. Kaiser test), the Boc-Lin-
OH linker (4) was preassembled in solution
48
 prior to am-
ide bond formation on the resin. Iterative cou-
pling/deprotection cycles of activated succinimidyl car-
bamate monomers (A) bearing either Trp, Val or His side 
chains were next performed under classical coupling condi-
tions and microwave irradiation. To note, an Orn-type 
monomer with an Alloc protecting group was incorporated 
in b position as a precursor of the Arg-type residue (Arg
U
) 
because standard guanidine side-chain protecting group 
could not be used conveniently with our synthesis ap-
proach. After chain elongation was completed, resin-bound 
intermediate 5 was treated with palladium-
tetrakis(triphenylphosphine) to remove the Alloc protection 
on the Orn
U
 side chain and guanidinylation was subse-
quently performed using 1-amidinopyrazole hydrochloride 
(6) to furnish resin-bound oligourea 7. After final Tos de-
protection of the two His
U
 side chains of 7, oligourea 8 
bearing a cysteamine moiety at first position
32 
was success-
fully released from the support by reduction of the disulfide 
bridge in the presence of dithiothreitol (DTT) in basic me-
dium and was recovered in 13%  
  
 Scheme 1. New methodology relying on the use of a disulfide bridge resin (3) to assemble oligourea 8 on solid support. Abbreviations 
not defined in text: BOP, (Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; DIEA, diisopropylethylamine; 
HOBt, hydroxybenzotriazole; Tos, tosyl; TFA, trifluoroacetic acid. 
 
yield after semi-preparative RP-HPLC purification. Het-
erodimer 2, was then obtained by disulfide bond formation 
between the C-terminal cysteine modified NCL multivalent 
ligand 9
36 
and the cysteamine spacer of oligourea 8 
(Scheme 2). The formation of the disulfide bridge was 
carried out in two steps by first activating oligourea 8 in 
presence of 2,2′-dithiobis(5-nitropyridine)49 and then add-
ing 9 to give 2 in 12% yield after semi-preparative RP-
HPLC purification (see experimental section for details). 
For direct comparison with 1 and in order to evaluate the 
effect on cellular delivery of shifting the cysteamine posi-
tion, 8 was homo-dimerized to provide Dim8 in 48% yield. 
To investigate the ability of the NCL ligand to transfect 
cells, we also carried out the homodimerization of 9 by 
DMSO oxidation procedure and the resulting Dim9 was 
recovered in 72% yield (see Supporting Information for 
details).  
Circular dichroism (CD) was used to confirm the 2.5-
helical conformation of the urea-segment composing 2. The 
CD spectra, measured either in transfection conditions (150 
mM NaCl) or in phosphate buffer (40 mM, pH 7.4), reveal 
a characteristic signature with a maximum of positive mo-
lar ellipticity at about 205 nm for 2 whereas at this wave-
length no band is observed for 9, thus supporting the pres-
ence of a 2.5-helical secondary structure in 2. It is notewor-
thy that the CD band at 205 nm is enhanced for 2 compared 
to precursor 8 suggesting here strengthening of the helical 
folding in the hybrid foldamer (see Figure S1 in the Sup-
porting Information). 
Plasmid DNA/hybrid CPF assemblies for cell delivery. 
We next investigated the capacity of 2, Dim8 and Dim9 to 
associate with a plasmid DNA and transfect cells. Their 
association with a reporter luciferase expression plasmid 
(p-Luc) was first explored by performing a gel retardation 
assay (see Figure S2 in the supporting information). Het-
erodimer 2 was found to interact particularly strongly with 
NA as revealed by the complete loss of p-Luc migration at 
a 2/p-Luc mass ratio of only 1. The same experiment with 
Dim8 showed comparable results to those recently reported 
for 1. 
The transfection efficiency of the new foldamers was then 
evaluated using luciferase as reporter gene and human 
embryonic kidney cells (HEK293) as target cells. CPF 1 
and the cationic lipid DOTAP were first used as positive 
controls. Increasing amounts of CPFs were mixed with a 
fixed amount of p-Luc and the transfection capacity of the 
various compounds was determined by measuring the lu-
minescence of cells (Figure 2a and Figure S3a). This assay 
showed that hybrid 2 exhibited promising transfection 
capacity with a level of luciferase expression upon trans-
fection of HEK293 cells that compares well with that of 
DOTAP and exceeds that of 1. It is noteworthy that despite 
the increase of molecular weight, the charge ratio (N/P) of 
2 (~3) remains slightly lower than that of 1 (~3.7) with an 
optimal 2/pDNA mass ratio (2.7) that is about 6 times less 
important to that of 1 (mass ratio = 16). Having a CPF 
active at low N/P and w/w ratios is indeed promising be-
cause that minimizes the risks of cytotoxicity and immune 
response potential (vide infra). Moreover, these low ratios 
ensure that no or only a few of CPF 2 remains uncom-
plexed in the transfection media. Moreover, these results 
also reveal that shifting the disulfide bridge from one ex-
  
4 
tremity in 1 to the other (Dim8) does not alter the transfec-
tion capacity of the CPF. In contrast, homodimer Dim9 
displayed poor transfection properties demonstrating here 
the key role played by the oligourea 2.5-helix component in 
the DNA association and transfection processes.  
With the aim to assess the transfection potential of 2, we 
conducted additional experiments in two other human cell 
lines: SV40-transformed MRC5 fibroblasts (MRC5-V2) 
and a breast cancer cell line (MDA-MB-231). Besides 
DOTAP, the 25 kDa cationic polymer b-PEIErreur ! Si-
gnet non défini. which is one of the best vectors to deliver 
genes and a “golden standard” in transfection assays was 
also introduced as comparator. The results obtained on 
these two cell lines unveiled that 2 is as good to transfect 
cells as these two commercially available reagents (Figure 
2b-c and Figure S3) at a N/P ratio of solely 1.5 - 3 and 
again superior luciferase expression was observed with 
foldaplexes composed of 2 compared to those formed ei-
ther in the presence of 1 or Dim8 (Figure 2c). 
Scheme 2. Synthetic routes to access Dim8 and 2 dimers through 
disulfide condensation of cysteamine-containing oligourea 8. 
 
Furthermore, when this transfection experiment was re-
peated on MDA-MB-231 cells by this time including as 
controls three CPPs described as being amongst the most 
potent CPPs for gene delivery, CPF 2 was systematically 
more effective than LAH4,
33
 LAH4-L1
50
 and Vpr55-82
51,52 
(Figure 2d).  
 
Figure 2. Evaluation of the transfection efficiency of 2 and re-
lated dimers 1, Dim8 and Dim9. Increasing amounts of transfec-
tion reagent were mixed with a constant amount of reporter plas-
mid (1.5 g of p-Luc per duplicate). The complexes were incu-
bated for 2-2.5 h in serum-free medium. Luciferase activity was 
measured 24–48 h post-transfection. The transfection efficiency is 
expressed as total light units per s per mg protein, and the average 
of duplicates is shown. Here, only are reported the conditions 
giving the highest luciferase expression. The complete assays are 
reported in the electronic supplementary information (see Figure 
S3, S5). a) Transfection of HEK293 cells with p-Luc in the pres-
ence of DOTAP (N/P = 2) and the four dimers 1, 2, Dim8 and 
Dim9. The mass (g) of compounds 1, 2, Dim8 and Dim9 used in 
the assay and the oligomer/pDNA charge ratio (N/P) are given in 
brackets; b) MRC5-V2 cells were transfected with DOTAP, PEI 
or 2 in the presence () or absence of concanamycin A (15 nM); 
c) Transfection levels obtained in MDA-MB-231 cells with 
DOTAP, b-PEI, 1, 2 and Dim8; d) Comparison of the transfection 
capacity of 2 vs. 3 CPPs namely Vpr55-82, LAH4-L1 and LAH4. 
To gain insight into the cell uptake pathway of this second 
generation of foldaplexes, we next evaluated p-Luc expres-
sion after inhibition of the endosome acidification by con-
canamycin A.
53
 In the presence of this drug, the transfec-
tion efficiency of b-PEI and 2 was diminished by more than 
100- and 1000-fold, respectively (Figure 2b), whilst that of 
DOTAP was almost unaltered (~3-fold less luciferase ex-
pression). At pH 7, the lipoplexes are indeed already proto-
nated. Similar to what was previously established for 
homodimer 1,
32
 these results emphasize that acidification 
of endocytic vesicles and therefore the protonation of His
U
 
residues are required to trigger the release of foldaplexes in 
the cytoplasm and consequently for an optimal activity of 
2.  
Additional information regarding the size and surface 
charge of the 2/pDNA foldaplex assemblies were gathered 
by performing dynamic light scattering experiments. In the 
absence of salt, we observed a majority of particles with a 
  
5 
size of about 100 nm that compares well to the result previ-
ously reported for foldaplexes formed with 1.
32 
In salt-rich 
conditions (150 mM NaCl), the foldaplexes were much 
larger with a mean diameter 10 times bigger ( 1000 nm). 
Thus, as earlier reported for 1 the presence of salts strongly 
influences the aggregation process.
32
 Finally, the surface 
charge of the 2/pDNA foldaplexes (generated at the opti-
mal mass ratio (2.7) for in vitro transfection) was investi-
gated by zeta potential measurement and found to be posi-
tive (above +27 mV) thus rendering the particles capable to 
enter cells. 
 
Figure 3. Comparison of the transfection efficiency of 2 in serum-
free or enriched media. The same conditions to those detailed in 
Figure 2 were applied. a) Transfection of MRC5-V2 cells with (•) 
or without the presence of 25% FCS. In this assay LAH4 peptide 
was included as control. The mass (g) of compound used in the 
assay and the charge ratio (N/P) are given in brackets; b) Trans-
fection of HEK293 cells with culture medium containing 50% of 
FCS (•); c) eGFP expression 48 h after transfection of HEK293 
cells with eGFP complexes without serum (photo on the left; with 
DOTAP as transfection agent) or in the presence of 50% FCS 
(right; with CPF 2) (n=2). 
NA transfection in serum-rich media. To further explore 
the potential of 2 as a gene carrier, we next determined the 
stability and activity of 2/pDNA foldaplexes in serum-rich 
media which is more realistic in terms of future in vivo use 
of this CPF-based delivery system. The recent finding that 
amphiphilic cationic oligourea sequences related to 8 dis-
play remarkable resistance to proteolysis and prolonged 
stability in biological fluids
42 
boded well for an improved 
behaviour of foldaplexes under such conditions. Up to 50% 
of foetal calf serum (FCS) was included in culture media of 
the three above mentioned cell lines and the level of 
luciferase expression was again monitored. DOTAP, b-PEI, 
LAH4 peptide and CPF 1 were included as references in 
this study (Figure 3a-b and Figure S4 for the MDA-MB-
231 cell line). Remarkably, the 2/p-Luc foldaplexes were 
found to be extremely stable in serum-containing media 
and no loss of transfection capacity was observed in cell 
culture composed of up to 50% of FCS. When 25% FCS 
was included in the MRC5-V2 cell medium, 2 compared 
favourably with DOTAP, b-PEI and LAH4. It is likely that 
the dramatically reduced transfection properties observed 
for LAH4 reflects its reduced serum-stability (Figure 3a). 
The same trend was observed on HEK293 cell line with a 
culture medium composed with 50% FCS. Whilst 2 exhib-
its a transfection efficiency unaltered in the absence or 
presence of serum (Figure 2a), at the opposite 1 showed a 
transfection capacity that was diminished by ~ 700 fold. 
Another feature of 2, worthy to emphasize is that in con-
trast to DOTAP and b-PEI where an increase of the vec-
tor/pDNA mass ratio is needed to compensate serum desta-
bilizing effects on lipo- and polyplexes,
54
 in the case of 2 
the same level of luciferase expression is observed in se-
rum-free or enriched conditions illustrating here the re-
markable capacity of this molecular transporter to deliver 
genes (Figure S5). 
In addition to these experiments, we analysed HEK293 
cells by fluorescence microscopy following transfection 
with a green fluorescent protein expression plasmid (eGFP) 
in culture medium containing 50% FCS. The observed 
eGFP expression was compared to that produced when 
DOTAP was employed as transfection agent in a serum-
free medium. As shown in Figure 3c, the number of GFP 
expressing cells 24 h after transfection with 2 is significant 
and surpasses the level of eGFP expression obtained with 
DOTAP. 
 
Figure 4. The different transfection reagents were mixed with a 
constant amount of reporter plasmid (2.25 μg per triplicate (a, b) 
and 1.5 μg per duplicate (c)) and the complexes were incubated 
for 2h40 with MDA-MB-231 cells in the absence or in the pres-
ence (grid bar) of 50% serum. In graph c) the red dots represent 
the amount of protein in g per well (y axis on the right of the 
graph). 
Cytotoxicity determination of hybrid CPF 2. The cyto-
toxicity of 2/p-Luc foldaplexes was assayed on MDA-MB-
231 cells by resorting to three different methods. First, cell 
  
6 
viability was evaluated by performing a 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay.
32
 The results show that 2 did not alter cell 
proliferation in culture medium containing or not 50% FCS 
(Figure 4a). Concurrently, the membrane integrity was 
assayed by measuring the extracellular activities of lactate 
dehydrogenase (LDH). The presence of this enzyme in the 
extracellular environment allows the detection of mem-
brane alteration. We find that b-PEI and DOTAP slightly 
perturbed the cell membrane with around 1.5 and 2-fold 
more extracellular LDH respectively than in the control 
experiment, whilst in the presence of 2 no cell membrane 
alteration is observed whatever the medium (i.e. +/- serum 
in the culture medium) (Figure 4b). The last assay con-
sisted in the determination of the total protein content after 
p-Luc transfection.
33
 The data are in agreement with the 
MTT assay and support the conclusion that CPF 2 seems to 
be harmless to the cells (Figure 4c). 
CONCLUSION 
In summary, we have developed an SPS approach featuring a 
cystamine-type resin and Boc chemistry to facilitate access to new 
oligourea sequences equipped with a cysteamine termination for 
further functionalization using thiol reactivity. This synthesis 
approach was applied to the preparation of a new generation of 
CPFs combining a cationic oligourea sequence and a NCL peptide 
ligand. One such heterodimer (2) was found to be highly potent to 
deliver pDNA to various human cells and to mediate effective 
gene expression. It compared favorably with the “golden stand-
ard” transfection reagents DOTAP and b-PEI as well as a number 
of known CPPs. Remarkably, the efficacy of foldaplexes com-
posed of 2 was not affected by the presence of up to 50% serum 
in the culture medium and cell cytotoxicity was low. For these 
reasons, the foldamer-peptide conjugates reported here may repre-
sent an alternative to overcome some of the current limitations of 
CPPs designed to deliver DNA. Future studies will aim at investi-
gating the cell internalization process and at determining if it 
occurs through a cell-surface nucleolin internalization pathway 
and whether it is associated with some cell selectivity.   
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